Deca-Durabolin 300 Beligas: Compound Profile
Deca-Durabolin 300 Beligas is a pharmaceutical-grade nandrolone decanoate research solution designed for in-vitro laboratory analysis. This injectable formulation contains 300mg/ml of nandrolone decanoate, a 19-nortestosterone derivative extensively studied in anabolic-androgenic steroid research. Scientists at Stroid UK Shop utilise this compound to investigate the molecular mechanisms underlying tissue-selective anabolic activity and long-acting ester pharmacokinetics. The Beligas pharmaceutical formulation provides consistent concentration for reproducible experimental protocols examining steroid receptor binding affinity and downstream signalling pathways.
Molecular Research Applications
Researchers examine nandrolone decanoate’s unique structural properties, including the absence of the C19 methyl group that confers reduced androgenic activity relative to testosterone. This compound enables investigation of selective androgen receptor modulation in muscle and bone tissue models. Studies focus on the decanoate ester’s extended release profile, allowing examination of sustained anabolic signalling over extended experimental periods. Laboratory investigations include analysis of nitrogen retention mechanisms, protein synthesis pathway activation, and collagen synthesis enhancement in cellular models. The compound serves as a reference standard for nandrolone decanoate research comparing tissue-specific responses across different experimental conditions.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Nandrolone Decanoate |
| Concentration | 300mg/ml |
| CAS Number | 360-70-3 |
| Molecular Formula | C₂₈H₄₄O₃ |
| Molecular Weight | 428.65 g/mol |
| Storage Temperature | Room temperature |
| Stability | 36 months sealed |
This research compound complements other investigational tools available through our comprehensive catalogue, including selective androgen receptor modulators and research peptides for comparative mechanistic studies. The pharmaceutical-grade formulation ensures consistent experimental results across repeated laboratory protocols.
Laboratory Compliance Notice
This product is exclusively intended for in-vitro research applications and laboratory analysis. Deca-Durabolin 300 Beligas is not approved for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols and disposal procedures when handling this compound. All experimental work should comply with institutional guidelines for controlled substance research and local regulatory requirements for anabolic steroid investigation.

